Epidermal growth factor augments adaptation following small bowel resection: Optimal dosage, route, and timing of administration

被引:55
作者
Shin, CE [1 ]
Helmrath, MA [1 ]
Falcone, RA [1 ]
Fox, JW [1 ]
Duane, KR [1 ]
Erwin, CR [1 ]
Warner, BW [1 ]
机构
[1] Univ Cincinnati, Coll Med, Childrens Hosp, Med Ctr,Dept Surg,Div Pediat Surg, Cincinnati, OH 45229 USA
关键词
EGF; adaptation; small bowel resection; intraperitoneal; orogastric; timing;
D O I
10.1006/jsre.1998.5336
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. In assorted animal models of small bowel resection (SBR), exogenous epidermal growth factor (EGF) has been shown to augment intestinal adaptation. This study was designed to elucidate the optimal dose, route, and timing of exogenous EGF to boost adaptation in our murine model of SBR. Methods. Male ICR mice underwent either 50% proximal SBR or sham surgery (bowel transection with reanastomosis) and then randomized to receive either saline or human recombinant EGF (5, 50, 150, or 300 mu g/kg/day) by twice daily intraperitoneal (i.p.) injection or orogastric gavage (o.g.). At 7 days, protein and DNA content, crypt depth, and villus height were determined in the ileum. The premium dose and route was then given for 1 week either during (1 week after SBR) or after the adaptive phase (1 month after SBR). Differences between group means were analyzed using ANOVA. A P < 0.05 was considered significant. Results. EGF enhanced DNA and protein content, crypt depth, and villus height to the greatest extent at a dosage of 50 mu g/kg/day by the o.g. route. EGF had no significant effect on enhancing adaptation when given after the adaptive response had already occurred. Conclusions. Intestinal adaptation is optimally enhanced by a specific dose and route of EGF. Exogenous EGF enhances adaptation only during the adaptive response to SBR and not after it has already taken place. Determination of the best circumstances for EGF administration will permit a systematic approach toward understanding a mechanism for the beneficial effect of EGF during intestinal adaptation. (C) 1998 Academic Press.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 31 条
[1]   THE EFFECT OF EPIDERMAL GROWTH-FACTOR (EGF) ON CELL-PROLIFERATION OF THE GASTROINTESTINAL MUCOSA IN RODENTS [J].
ALNAFUSSI, AI ;
WRIGHT, NA .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1982, 40 (01) :63-69
[2]  
BAMBA T, 1993, GASTROENTEROL JPN, V28, P511
[3]   EFFECT OF TRANSAMNIOTIC ADMINISTRATION OF EPIDERMAL GROWTH-FACTOR ON FETAL RABBIT SMALL-INTESTINAL NUTRIENT TRANSPORT AND DISACCHARIDASE DEVELOPMENT [J].
BUCHMILLER, TL ;
SHAW, KS ;
CHOPOURIAN, HL ;
LLOYD, KCK ;
GREGG, JP ;
RIVERA, FA ;
LAM, ML ;
DIAMOND, JM ;
FONKALSRUD, EW .
JOURNAL OF PEDIATRIC SURGERY, 1993, 28 (10) :1239-1244
[5]   EPIDERMAL GROWTH-FACTOR ENHANCES INTESTINAL ADAPTATION AFTER MASSIVE SMALL-BOWEL RESECTION [J].
CHAET, MS ;
ARYA, G ;
ZIEGLER, MM ;
WARNER, BW .
JOURNAL OF PEDIATRIC SURGERY, 1994, 29 (08) :1035-1039
[6]  
COHEN S, 1983, CANCER-AM CANCER SOC, V51, P1787, DOI 10.1002/1097-0142(19830515)51:10<1787::AID-CNCR2820511004>3.0.CO
[7]  
2-A
[8]  
FELDMAN EJ, 1976, GASTROENTEROLOGY, V70, P712
[9]   DOES RESECTION ENHANCE THE RESPONSE OF THE INTESTINE TO UROGASTRONE-EPIDERMAL GROWTH-FACTOR IN THE RAT [J].
GOODLAD, RA ;
SAVAGE, AP ;
LENTON, W ;
GHATEI, MA ;
GREGORY, H ;
BLOOM, SR ;
WRIGHT, NA .
CLINICAL SCIENCE, 1988, 75 (02) :121-126
[10]   RELATIONSHIP BETWEEN EPIDERMAL GROWTH-FACTOR IN MOUSE SUBMANDIBULAR GLANDS, PLASMA, AND BILE - EFFECTS OF CATECHOLAMINES AND FASTING [J].
GRAU, M ;
RODRIGUEZ, C ;
SOLEY, M ;
RAMIREZ, I .
ENDOCRINOLOGY, 1994, 135 (05) :1854-1862